Australian (ASX) Stock Market Forum

RBY - Rockeby Biomed

Jump to new
RBY just annouced that they got approval to market their anti avian flu test in Europe and Australia. Hopefully this will translate into new revenue streams.
 
Just listened to the RBY Boardroom interview and I think there is no doubt revenue will increase. There is already some revenue from the human-avian flu test kits and Dr.Sze Wee Tan suggests it may only be a couple of months before we see a marked increase. All sounds very positive and I'm happy to be holding.
 
semtar said:
Just listened to the RBY Boardroom interview and I think there is no doubt revenue will increase. There is already some revenue from the human-avian flu test kits and Dr.Sze Wee Tan suggests it may only be a couple of months before we see a marked increase. All sounds very positive and I'm happy to be holding.
Click to expand...

Semtar,

It is nice to be hearing some positive about this stock on this forum. I am the same I am holding and I think the second half of this year should be interesting. I am forecasting increase revenue and the start of their venture in China should give them a big boost. I like what I am hearing from RBY so it is I admit a very speculative stock but what do you expect at this price.
 
Fab said:
Semtar,

It is nice to be hearing some positive about this stock on this forum. I am the same I am holding and I think the second half of this year should be interesting. I am forecasting increase revenue and the start of their venture in China should give them a big boost. I like what I am hearing from RBY so it is I admit a very speculative stock but what do you expect at this price.
Click to expand...
I expect RBY will struggle to break over 3cents.
 
rederob said:
I expect RBY will struggle to break over 3cents.
Click to expand...

I support this comment. From a charting perspective it doesn't look like it's going anywhere in a hurry. Shame though as I'm interested in this. I held it from 2.5-3.2 in the last up trend. I've wanted to get back in but I can't see enough upside any time soon to convince me to get back in.
 
britishcarfreak said:
I support this comment. From a charting perspective it doesn't look like it's going anywhere in a hurry. Shame though as I'm interested in this. I held it from 2.5-3.2 in the last up trend. I've wanted to get back in but I can't see enough upside any time soon to convince me to get back in.
Click to expand...

I have to agree too 3c is a strong resistance nevertheless this won't be a problem after a good announcement. Remember this stock move by strike and I strongly believe there will be more spike once some more revenue announcements are made:)
 
Fab said:
I have to agree too 3c is a strong resistance nevertheless this won't be a problem after a good announcement. Remember this stock move by strike and I strongly believe there will be more spike once some more revenue announcements are made:)
Click to expand...
Judging by the chart for RBY the influence of STC and Fab has worn off.
There is a hole in this forum since STC (alias krisbarry) has curbed his enthusiasm.
Some people are destined to be great stock pickers, and I truly feel that krisbarry had a gift that many will fail to appreciate. Akin to his stock.
 
rederob said:
Judging by the chart for RBY the influence of STC and Fab has worn off.
There is a hole in this forum since STC (alias krisbarry) has curbed his enthusiasm.
Some people are destined to be great stock pickers, and I truly feel that krisbarry had a gift that many will fail to appreciate. Akin to his stock.
Click to expand...

Ahh dear Rob, you truly are the Master of witty badinage! I do miss you.

You know I think this may go somewhere....it isn't sliding into the mire as much as I thought it might.

I have noticed once the lovely Kris left off humping something, eventually some of the stocks recovered. I am waiting for this to morph into a miner and it may well do something interesting.
 
Actually I am wondering what is now going on with this one. The lack of information on sales is worrying me. I still think this company can do well but I have to say it is harder to resist selling this stock to move on more secure high return one such as the miners at the moment.
Has anyone got any news on RBY worth sharing?
 
Yesterday announcement sounds like good news: "Singapore`s Ministry of Health approves the use of OraQuick" my only problem is there are not dollars signs associated to it:)
 
Ann.

16 Aug 2007 09:36 ! Japan Patent Granted for CanDia5

One of the few positive shares this morning.

Share price up 20% to 2.4c
 
I think what might eventually give a big boost to RBY is when they finalise their entry in the chinese market which I understand is due to be annouce anytime soon. I am hoping this will push the share price much much higher when we get the news
 
This sounds pretty positive to me:
The Board of Rockeby biomed Limited (“Rockeby”) is pleased to present its Preliminary Final
Report for 30 June 2007. The Group had record sales that exceeded the million dollar mark for the
first time in its operating history. Total revenue for the year was A$ 1,185,929 as compared to
A$633,627 in the previous year. Revenue generated from product sales came to A$1,124,312 as
compared A$280,381 in the previous year.
The Group’s Avian Flu diagnostic kit continues to be the key product generating approximately
90% of product sales revenue for the year. The increase in Avian Flu diagnostic kit sales was due to
its successful rollout to Indonesia, Europe and the Middle East. Other products which contributed to
current year’s revenue included CanDia5 ®, Oraquick and Pepp ®.
Gross margin improved significantly from 4% to 60% due to significant improvements in the cost
base for the Avian flu diagnostic test. This was made possible by the acquisition of the intellectual
property rights to this product and the team’s effort in continuous monitoring of costs, without
compromising on quality.
Total operating expense for the year (excluding depreciation and amortization) at A$4,329,571 was
lower when compared to previous year’s A$4,412,501. Included in operating expense of $4,329,571
was an expense of $250,000 arising out of the Company’s China Anheal project. Bulk of this cost
was for financial and legal due diligence as well as the cost of China consultant. Excluding the cost
of the Anheal project, the total operating expense for the year would be $4,079,571 . Consequently,
operating expense in support of the Group’s operation was in effect lower than the previous year.
This was the result of the rationalisation exercise carried out by the Company at the end of the
previous financial year of which the benefit is seen in the current financial year.
The Group’s net cash position at the close of the financial year was $658,432 . At the end of the
period, cash and cash equivalent, net of overdraft, was A$1,302,432. Included in Cash and cash
equivalents is an amount of $644,000 which represents money held in trust relating to a proposed
placement of shares to sophisticated investors. Subsequent to year end, the Group has decided to
cancel the placement and this money has since been returned to the investors.:)
 
Any idea what might be the big news on this stock that caused the suspension of trade since the 10th of January. It seems like it is going to be a good one as the annoucement mentions that it is to annouce a possible contract agreement. I hope RBY will spike again :)
 

Similar threads

kahuna1
All trading needs to cease for 14 days prior to Monday open in Sydney
2 3 4
Replies
75
Views
11K
divs4ever
divs4ever
Top